Nasus pharma Announces Launch of TaffiX ™ – a personal “anti-virus” product in

Tel Aviv, July 2nd 2020. 

Tel Aviv based Nasus Pharma ( ) a biopharma company focused on intranasal drug delivery is pleased to announce the launch in Israel of TaffiX – a “personal anti-virus” nasal powder spray indicated for blocking viruses in the nasal cavity .  

The marketing, sales & distribution partner for the Israeli market is CTS LTD – one of the largest and well-established pharma companies in Israel.  

TaffiX is approved by Israel Ministry of Health  as a Medical Device, and is sold in pharmacies and pharmacy chains in Israel

For further information please use the following links: and

Share this post

Share on facebook
Share on linkedin
Share on google
Share on whatsapp
Share on twitter
Share on pinterest
Share on email